Monday, June 15

Browsing: Lurbinectedin

Survivors

Lurbinectedin Misses Survival End Point in Second-Line SCLC Trial

By NewsCancerJune 12, 20260

Lurbinectedin (Zepzelca) with or without irinotecan did not meet the primary end point of overall survival (OS) compared with investigator’s…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.